Seres Therapeutics

Read more
Eric D. Shaff's photo - President & CEO of Seres Therapeutics

President & CEO

Eric D. Shaff

CEO Approval Rating

87/100

Founded

2010

Status

PublicIndependent CompanyNASDAQMCRB

Social Links

Annual Revenue
$140.7M
Employees
330
Funding
$267.9M

Seres Therapeutics Competitors and Alternatives

1
3
5
7
9
2
4
6
8
10
See more competitor data

Seres Therapeutics Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$140.7M

Seres Therapeutics's revenue is the ranked 3rd among it's top 10 competitors. The top 10 competitors average 241.5M. Over the last four quarters, Seres Therapeutics's revenue has decreased by 71.6%. Specifically, in Q1 2022's revenue was $1.5M; in Q4 2021, it was $7.2M; in Q3 2021, it was $126.7M; in Q2 2021, Seres Therapeutics's revenue was $5.3M.

Seres Therapeutics News

Seres Therapeutics Press Releases

Seres Therapeutics Headquarters

200 Sidney Street

Cambridge, Massachusetts02139

1-617-945-9626

Driving Directions »

Seres Therapeutics Summary

ABOUT

Overview

Seres Therapeutics is a clinical-stage biotherapeutic company that researches and develops ecobiotic therapeutic products. Seres Therapeutics was founded in 2010. Seres Therapeutics' headquarters is located in Cambridge, Massachusetts, USA 02139. Ser...

CEO

Seres Therapeutics's President & CEO, Eric D. Shaff, currently has an approval rating of 87%. Seres Therapeutics's primary competitors are Evelo Biosciences, Second Genome & Vedanta.

Acquisitions

There have been no acquisitions found related to Seres Therapeutics

Frequently Asked Questions about Seres Therapeutics

  1. When was Seres Therapeutics founded?

    Seres Therapeutics was founded in 2010
  2. Who is Seres Therapeutics's CEO?

    Seres Therapeutics's CEO is Eric D. Shaff
  3. How much revenue does Seres Therapeutics generate?

    Seres Therapeutics generates $140.7M in revenue
  4. How much funding does Seres Therapeutics have?

    Seres Therapeutics has historically raised $267.9M in funding
  5. Where is Seres Therapeutics's headquarters?

    Seres Therapeutics's headquarters is in Cambridge Massachusetts, USA
  1. How many employees does Seres Therapeutics have?

    Seres Therapeutics has 330 employees
  2. What sector does Seres Therapeutics operate in?

    Seres Therapeutics is in Biotechnology
  3. Who are Seres Therapeutics's competitors?

    Seres Therapeutics's top competitors are Evelo Biosciences, Second Genome, Vedanta
  4. Who has Seres Therapeutics invested in?

    Seres Therapeutics's has invested in companies such as Evelo Biosciences

Trending Companies